Establishment and characterization of three stable Basal/HER2-positive breast cancer cell lines derived from Chinese breast carcinoma with identical missense mutations in the DNA-binding domain of TP53

Abstract Background Basal/human epidermal growth factor receptor (HER)2-positive (HER2+) breast cancer is resistant to monoclonal antibody (herceptin) treatment. There are currently only three basal/HER2+ breast cancer cell lines available, but they are not from Chinese populations. Methods Three im...

全面介绍

书目详细资料

Principais autores:	Fei Zhou, Yanhua Zhang, Xiufang Xu, Jingfeng Luo, Fang Yang, Linbo Wang, Shuduo Xie, Jihong Sun, Xiaoming Yang
格式:	Artigo
语言:	Inglês
出版:	BMC 2018-08-01
丛编:	Cancer Cell International
主题:	Basal/HER2-positive Breast cancer cell lines Invasive ductal breast carcinoma Epithelial cell STR
在线阅读:	http://link.springer.com/article/10.1186/s12935-018-0617-9
标签:	添加标签 没有标签, 成为第一个标记此记录!